Search Prime Contracts

75F40118D10053-75F40119F19002

Delivery Order

Overview

Government Description
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER), BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE: DEVELOPMENT OF NEW AND INNOVATIVE METHODS FOR AUTOMATED REPORTING FOR CBER-REGULATED BIOLOGIC
Awardee
International Business Machines Corporation
Awarding / Funding Agency
FDA Office of Acquisition and Grant Services (OAGS) [HHS - FDA]
NAICS
518210 - Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
PSC
B537 - Special Studies/Analysis- Medical/Health
Place of Performance
Bethesda, MD 20817 United States
Pricing
Time And Materials
Set Aside
None
Extent Competed
Full And Open Competition
Related Opportunity
Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Products (FDA-18-223-SOL-1196210)
Analysis Notes
Predecessor This appears to be a continuation of a prior contract 75F40118D10053-75F40118F01001.
Successor The following contract appears to have succeeded this one 75F40118D10022-75F40120F19003.
Subcontracting Plan This Delivery Order has an Individual Subcontract Plan. The Department of Health and Human Services has an overall small business subcontracting goal of 32%
International Business Machines Corporation was awarded Delivery Order 75F40119F19002 (75F401-19-F-19002) worth up to $7,081,492 by the FDA Office of Acquisition and Grant Services in September 2019. The contract has a duration of 1 year and was awarded through solicitation Biologics Effectiveness and Safety (BEST) Initiative: Development of New and Innovative Methods for Automated Reporting for CBER-Regulated Products full & open with NAICS 518210 and PSC B537 via subject to multiple award fair opportunity acquisition procedures with 3 bids received. This contract was awarded through vehicle Biologics Effectiveness and Safety (BEST) Initiative - New and Innovative Methods for Automated Reporting.

Status
(Closed)

Last Modified 2/23/24
Period of Performance
9/27/19
Start Date
9/26/20
Current End Date
9/26/20
Potential End Date
100% Complete

Obligations
$7.1M
Total Obligated
$7.1M
Current Award
$7.1M
Potential Award
100% Funded

Award Hierarchy

Vehicle

Biologics Effectiveness and Safety (BEST) Initiative - New and Innovative Methods for Automated Reporting

Indefinite Delivery Contract

75F40118D10053

Delivery Order

75F40118D10053-75F40119F19002

Subcontracts

0

Activity Timeline

Interactive chart of timeline of amendments to 75F40118D10053-75F40119F19002

Labor Services Billing

Annual labor billing rates and FTE reported for 75F40118D10053-75F40119F19002

Year Services Invoiced Hours FTE Blended Rate
2019 $102,748 858.5 0.4 $119.68

Opportunity Lifecycle

Procurement history for 75F40118D10053-75F40119F19002

Transaction History

Modifications to 75F40118D10053-75F40119F19002

People

Suggested agency contacts for 75F40118D10053-75F40119F19002

Competition

Number of Bidders
3
Solicitation Procedures
Subject To Multiple Award Fair Opportunity
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No

Other Categorizations

Subcontracting Plan
Individual Subcontract Plan
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
VV9KH3L99VE3
Awardee CAGE
3BXY7
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhssnajam1
Last Modified By
hhssnajam1
Approved By
hhssnajam1

Legislative

Legislative Mandates
Labor Standards
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Representative
Jamie Raskin

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) Consumer and occupational health and safety Other services from non-Federal sources (25.2) $7,287,063 100%
Modified: 2/23/24